Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Bearish flow noted in Merck (MRK) with 177,294 puts trading, or 7x expected. Most active are Feb-25 98 puts and Feb-25 100 puts, with total ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

SEC Filings provided by EDGAR Online, Inc.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

After hours: 7:59:57 p.m. EST Loading Chart for MRK ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...